Teprotumumab may reduce the cross-sectional area of the extraocular muscle
- Posted on: Mar 16 2023
- Leave a response
While it has been theorized that proptosis reduction in patients with thyroid eye disease after teprotumumab infusion is due to decreased extraocular muscle size, this has not been fully quantified.
Source: AAO
Posted in: Uncategorized
